8-K: Immunome Inc. Announces Results of 2024 Annual Meeting of Stockholders

Immunome Inc. held its 2024 Annual Meeting of Stockholders on June 12, 2024, where stockholders elected two Class I Directors and ratified the selection of Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2024.

Summary

• Immunome Inc. conducted its 2024 Annual Meeting of Stockholders on June 12, 2024.
• As of the record date, April 25, 2024, there were 59,943,368 shares of common stock eligible to vote.
• The stockholders elected Clay B. Siegall, Ph.D. and Carol A. Schafer as Class I Directors, each to serve until the 2027 Annual Meeting.
• Clay B. Siegall received 43,295,914 votes for, 80,139 votes withheld, and 6,682,195 broker non-votes.
• Carol A. Schafer received 33,452,580 votes for, 9,923,473 votes withheld, and 6,682,195 broker non-votes.
• The stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• The ratification received 50,008,641 votes for, 29,664 votes against, 19,943 abstentions, and no broker non-votes.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures, indicating a neutral to slightly positive sentiment due to the successful completion of the annual meeting.

Positives

• The election of directors and ratification of the auditor were successfully completed.
• The high number of votes in favor of the proposals indicates strong shareholder support.

Industry Context

This announcement is a routine corporate governance event for a publicly traded company, ensuring compliance with regulatory requirements and shareholder engagement.

Comparison to Industry Standards

• The election of directors and ratification of auditors are standard practices for publicly traded companies like Immunome.
• The voting results are typical for such meetings, with the majority of votes cast in favor of the board's recommendations.
• Companies such as Amgen, Regeneron, and Gilead also conduct similar annual meetings to elect directors and ratify auditors.

Stakeholder Impact

• Shareholders have exercised their voting rights to elect directors and ratify the auditor.
• The successful completion of the meeting ensures the company's continued compliance with corporate governance standards.

Key Dates

Keywords

Annual Meeting, Stockholders, Directors, Auditor, Ernst & Young, Corporate Governance, Voting Results